Long-term, Non-interventional Study of Recipients of Tecartus for Treatment of Adult Patients With Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL) or Adult Patients With R/R B-Cell Precursor Acute Lymphoblastic Leukemia (ALL)

01/03/2022
04/12/2025
EU PAS number:
EUPAS45813
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

KT-EU-472-6036-appendix-16.1.1-protocol version 1.2_f-redact_reducedsize

English (8 MB - PDF) View document
Updated protocol

KT-EU-472-6036-appendix-16.1.1-protocol amendment 3.0_f-redact.pdf

First published: 22/11/2025
English (13.94 MB - PDF) View document

KT-EU-472-6036-appendix-16.1.1-protocol amendment 5-version 2.2-f-redact 1.pdf

First published: 07/05/2025
English (11.21 MB - PDF) View document
Study results
Study report
Other information